Ronit Simantov - Nov 15, 2022 Form 3 Insider Report for Gamida Cell Ltd. (GMDA)

Role
CMO & Chief Scientific Officer
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact
Stock symbol
GMDA
Transactions as of
Nov 15, 2022
Transactions value $
$0
Form type
3
Date filed
2/10/2023, 06:49 PM
Previous filing
Jun 22, 2022
Next filing
Feb 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GMDA Ordinary Shares 117K Nov 15, 2022 Direct F1, F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GMDA Employee Share Option (Right to Buy) Nov 15, 2022 Ordinary Shares 187K $4.90 Direct F4
holding GMDA Employee Share Option (Right to Buy) Nov 15, 2022 Ordinary Shares 49.4K $11.01 Direct F5
holding GMDA Employee Share Option (Right to Buy) Nov 15, 2022 Ordinary Shares 49K $4.70 Direct F6
holding GMDA Employee Share Option (Right to Buy) Nov 15, 2022 Ordinary Shares 54K $9.51 Direct F7
holding GMDA Employee Share Option (Right to Buy) Nov 15, 2022 Ordinary Shares 79.7K $2.93 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person became a Section 16 officer, effective November 15, 2022. This report discloses ordinary shares beneficially owned by the Reporting Person as of the date on which the Reporting Person became subject to the reporting obligation on Form 3 under Section 16 of the Securities Exchange Act of 1934, as amended.
F2 Includes an award of 13,300 restricted share units, 33% of which vested on January 28, 2023, 33% of which shall vest on January 28, 2024 and 34% of which shall vest on January 28, 2025, subject to the Reporting Person's continuous service through each such vesting date.
F3 Includes an award of 38,800 restricted share units, 50% of which vested on January 28, 2023 and 50% of which shall vest on January 28, 2024, subject to the Reporting Person's continuous service through such vesting date.
F4 Immediately exercisable.
F5 One fourth (1/4th) of the shares subject to the option award vested on March 13, 2020, and one twelfth (1/12th) of the remaining shares subject to the option award vested or shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F6 One fourth (1/4th) of the shares subject to the option award vested on February 24, 2021, and one twelfth (1/12th) of the remaining shares subject to the option award vested or shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F7 One fourth (1/4th) of the shares subject to the option award vested on February 25, 2022, and one twelfth (1/12th) of the remaining shares subject to the option award vested or shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
F8 One fourth (1/4th) of the shares subject to the option award shall vest on January 28, 2023, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney